BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32816938)

  • 1. Calcitonin negative medullary thyroid cancer in ectopic thyroid tissue: a rare diagnosis in an unusual location.
    Montgomery G; Collins L; Coghlin C; Ullah R
    BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32816938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
    Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
    BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
    Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
    Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin-negative medullary thyroid carcinoma: the 'triple-negative' phenotype.
    Murphy DC; Johnson SJ; Aspinall S
    Ann R Coll Surg Engl; 2020 Mar; 102(3):e63-e66. PubMed ID: 31841033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
    Gambardella C; Offi C; Patrone R; Clarizia G; Mauriello C; Tartaglia E; Di Capua F; Di Martino S; Romano RM; Fiore L; Conzo A; Conzo G; Docimo G
    BMC Endocr Disord; 2019 May; 19(Suppl 1):45. PubMed ID: 31142313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current Literature.
    Cipri C; Vescini F; Torresan F; Pennelli G; Pelizzo MR; Triggiani V; Guastamacchia E; Grimaldi F
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):226-229. PubMed ID: 30574858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medullary Thyroid Carcinoma: Imaging.
    Delorme S; Raue F
    Recent Results Cancer Res; 2015; 204():91-116. PubMed ID: 26494385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma.
    Martins A; Gonçalves A; Almeida T; Midões A
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29895542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels.
    Fanget F; Demarchi MS; Maillard L; Lintis A; Decaussin M; Lifante JC
    Br J Surg; 2021 Sep; 108(9):1064-1071. PubMed ID: 33899100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spindle cell variant of medullary thyroid carcinoma: a clinicopathologic study of four cases.
    Wang YX; Yang SJ
    Diagn Pathol; 2021 Nov; 16(1):112. PubMed ID: 34838061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma.
    Trimboli P; Lauretta R; Barnabei A; Valabrega S; Romanelli F; Giovanella L; Appetecchia M
    Int J Biol Markers; 2018 May; 33(2):156-160. PubMed ID: 29707993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing and extension of lymphadenectomy in medullary thyroid carcinoma: A case series from a single institution.
    Polistena A; Sanguinetti A; Lucchini R; Galasse S; Monacelli M; Avenia S; Boccolini A; Johnson LB; Avenia N
    Int J Surg; 2017 May; 41 Suppl 1():S70-S74. PubMed ID: 28506418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Jin LX; Moley JF
    Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain metastasis from calcitonin-negative medullary thyroid carcinoma.
    Baptista PF; Fonseca LCM; Carvalho AFC; Silva SNVD; Freitas CRO
    Ann Endocrinol (Paris); 2022 Aug; 83(4):258-260. PubMed ID: 35537523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CALCITONIN SECRETORY INDEX AND UNSUSPECTED NODAL DISEASE IN MEDULLARY THYROID CARCINOMA.
    Filimon S; Payne RJ; Black MJ; Hier MP; Mlynarek AM; Forest VI; Tamilia M
    Endocr Pract; 2018 May; 24(5):460-467. PubMed ID: 29847167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
    Chen SW; Chen YK
    World J Surg Oncol; 2017 Dec; 15(1):230. PubMed ID: 29284496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micro-medullary thyroid carcinoma: a diagnosis not to be missed.
    Lacout A; Isaac S; Marcy PY
    Postgrad Med J; 2015 Apr; 91(1074):236-7. PubMed ID: 25862709
    [No Abstract]   [Full Text] [Related]  

  • 18. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
    Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of FoxA1 expression in thyroid tumors.
    Nonaka D
    Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, pathologic, and immunohistochemical prognostic factors in dogs with thyroid carcinoma.
    Campos M; Ducatelle R; Rutteman G; Kooistra HS; Duchateau L; de Rooster H; Peremans K; Daminet S
    J Vet Intern Med; 2014; 28(6):1805-13. PubMed ID: 25252127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.